Share Price and Basic Stock Data
Last Updated: May 31, 2025, 8:21 pm
| PEG Ratio | 0.00 |
|---|
Competitors of Achyut Healthcare Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Lactose (India) Ltd | 134 Cr. | 95.0 | 247/84.3 | 26.0 | 41.7 | 0.00 % | 12.9 % | 9.75 % | 10.0 |
| MPS Pharmaa Ltd | 5.27 Cr. | 2.76 | 4.33/2.50 | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 | |
| Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 39.9 Cr. | 53.8 | 94.9/44.5 | 8.73 | 0.00 % | 41.5 % | 14.4 % | 10.0 | |
| Gujarat Inject (Kerala) Ltd | 41.1 Cr. | 28.0 | 29.1/13.1 | 40.3 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Industry Average | 18,354.98 Cr | 1,129.60 | 88.53 | 194.54 | 0.32% | 16.70% | 15.22% | 6.19 |
Quarterly Result
| Metric | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 2.71 | 1.34 | 1.89 | 0.81 | 1.48 | 4.65 | 2.13 | 0.92 |
| Expenses | 2.56 | 1.53 | 1.87 | 1.10 | 1.45 | 4.66 | 2.21 | 1.04 |
| Operating Profit | 0.15 | -0.19 | 0.02 | -0.29 | 0.03 | -0.01 | -0.08 | -0.12 |
| OPM % | 5.54% | -14.18% | 1.06% | -35.80% | 2.03% | -0.22% | -3.76% | -13.04% |
| Other Income | 0.02 | 0.13 | 0.23 | 0.36 | 0.32 | 0.41 | 0.56 | 0.36 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Profit before tax | 0.17 | -0.07 | 0.25 | 0.07 | 0.35 | 0.40 | 0.47 | 0.24 |
| Tax % | 47.06% | -28.57% | 0.00% | 114.29% | 22.86% | 20.00% | 25.53% | 16.67% |
| Net Profit | 0.09 | -0.05 | 0.24 | -0.01 | 0.26 | 0.31 | 0.35 | 0.20 |
| EPS in Rs | 0.01 | -0.00 | 0.02 | -0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
Last Updated: May 31, 2025, 7:11 am
Below is a detailed analysis of the quarterly data for Achyut Healthcare Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 0.92 Cr.. The value appears to be declining and may need further review. It has decreased from 2.13 Cr. (Sep 2024) to 0.92 Cr., marking a decrease of 1.21 Cr..
- For Expenses, as of Mar 2025, the value is 1.04 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.21 Cr. (Sep 2024) to 1.04 Cr., marking a decrease of 1.17 Cr..
- For Operating Profit, as of Mar 2025, the value is -0.12 Cr.. The value appears to be declining and may need further review. It has decreased from -0.08 Cr. (Sep 2024) to -0.12 Cr., marking a decrease of 0.04 Cr..
- For OPM %, as of Mar 2025, the value is -13.04%. The value appears to be declining and may need further review. It has decreased from -3.76% (Sep 2024) to -13.04%, marking a decrease of 9.28%.
- For Other Income, as of Mar 2025, the value is 0.36 Cr.. The value appears to be declining and may need further review. It has decreased from 0.56 Cr. (Sep 2024) to 0.36 Cr., marking a decrease of 0.20 Cr..
- For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
- For Depreciation, as of Mar 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.01 Cr. (Sep 2024) to 0.00 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Mar 2025, the value is 0.24 Cr.. The value appears to be declining and may need further review. It has decreased from 0.47 Cr. (Sep 2024) to 0.24 Cr., marking a decrease of 0.23 Cr..
- For Tax %, as of Mar 2025, the value is 16.67%. The value appears to be improving (decreasing) as expected. It has decreased from 25.53% (Sep 2024) to 16.67%, marking a decrease of 8.86%.
- For Net Profit, as of Mar 2025, the value is 0.20 Cr.. The value appears to be declining and may need further review. It has decreased from 0.35 Cr. (Sep 2024) to 0.20 Cr., marking a decrease of 0.15 Cr..
- For EPS in Rs, as of Mar 2025, the value is 0.01. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.01.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 7, 2025, 5:32 pm
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 0.67 | 0.33 | 0.27 | 4.05 | 2.70 | 6.14 | 6.78 |
| Expenses | 0.66 | 0.32 | 0.26 | 4.08 | 2.97 | 6.12 | 6.87 |
| Operating Profit | 0.01 | 0.01 | 0.01 | -0.03 | -0.27 | 0.02 | -0.09 |
| OPM % | 1.49% | 3.03% | 3.70% | -0.74% | -10.00% | 0.33% | -1.33% |
| Other Income | 0.00 | 0.01 | 0.00 | 0.14 | 0.59 | 0.73 | 0.97 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Profit before tax | 0.01 | 0.02 | 0.01 | 0.10 | 0.31 | 0.74 | 0.87 |
| Tax % | 300.00% | 0.00% | 0.00% | 60.00% | 25.81% | 22.97% | |
| Net Profit | -0.01 | 0.01 | 0.01 | 0.04 | 0.23 | 0.57 | 0.66 |
| EPS in Rs | -0.02 | 0.02 | 0.02 | 0.00 | 0.01 | 0.02 | 0.02 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 200.00% | 0.00% | 300.00% | 475.00% | 147.83% |
| Change in YoY Net Profit Growth (%) | 0.00% | -200.00% | 300.00% | 175.00% | -327.17% |
Achyut Healthcare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2019-2020 to 2023-2024.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 56% |
| 3 Years: | -9% |
| TTM: | -50% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 123% |
| 3 Years: | 140% |
| TTM: | -4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 52% |
| 1 Year: | -2% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | 2% |
| Last Year: | 2% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 14, 2024, 5:59 pm
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.25 | 0.25 | 0.25 | 6.74 | 9.35 | 16.83 | 16.83 |
| Reserves | -0.05 | -0.04 | 0.00 | 2.34 | 5.18 | 13.93 | 14.28 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.04 | 0.06 | 0.25 | 0.86 | 0.81 | 0.19 | 0.82 |
| Total Liabilities | 0.24 | 0.27 | 0.50 | 9.94 | 15.34 | 30.95 | 31.93 |
| Fixed Assets | 0.00 | 0.00 | 0.00 | 0.03 | 0.05 | 0.06 | 0.05 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 3.49 | 9.16 | 13.97 |
| Investments | 0.00 | 0.00 | 0.00 | 1.70 | 1.30 | 0.00 | 0.00 |
| Other Assets | 0.24 | 0.27 | 0.50 | 8.21 | 10.50 | 21.73 | 17.91 |
| Total Assets | 0.24 | 0.27 | 0.50 | 9.94 | 15.34 | 30.95 | 31.93 |
Below is a detailed analysis of the balance sheet data for Achyut Healthcare Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is 16.83 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 16.83 Cr..
- For Reserves, as of Sep 2024, the value is 14.28 Cr.. The value appears strong and on an upward trend. It has increased from 13.93 Cr. (Mar 2024) to 14.28 Cr., marking an increase of 0.35 Cr..
- For Borrowings, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is 0.82 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.19 Cr. (Mar 2024) to 0.82 Cr., marking an increase of 0.63 Cr..
- For Total Liabilities, as of Sep 2024, the value is 31.93 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 30.95 Cr. (Mar 2024) to 31.93 Cr., marking an increase of 0.98 Cr..
- For Fixed Assets, as of Sep 2024, the value is 0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.06 Cr. (Mar 2024) to 0.05 Cr., marking a decrease of 0.01 Cr..
- For CWIP, as of Sep 2024, the value is 13.97 Cr.. The value appears strong and on an upward trend. It has increased from 9.16 Cr. (Mar 2024) to 13.97 Cr., marking an increase of 4.81 Cr..
- For Investments, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2024, the value is 17.91 Cr.. The value appears to be declining and may need further review. It has decreased from 21.73 Cr. (Mar 2024) to 17.91 Cr., marking a decrease of 3.82 Cr..
- For Total Assets, as of Sep 2024, the value is 31.93 Cr.. The value appears strong and on an upward trend. It has increased from 30.95 Cr. (Mar 2024) to 31.93 Cr., marking an increase of 0.98 Cr..
Notably, the Reserves (14.28 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|
| Free Cash Flow | 0.01 | 0.01 | 0.01 | -0.03 | -0.27 | 0.02 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|
| Debtor Days | 54.48 | 188.03 | 378.52 | 18.02 | 36.50 | 24.37 |
| Inventory Days | 0.00 | 0.00 | 158.70 | 14.29 | 59.59 | 3.96 |
| Days Payable | 380.87 | 41.78 | 55.87 | 9.24 | ||
| Cash Conversion Cycle | 54.48 | 188.03 | 156.34 | -9.46 | 40.22 | 19.09 |
| Working Capital Days | 76.27 | 210.15 | 216.30 | 603.83 | 1,257.22 | 1,242.43 |
| ROCE % | 9.76% | 4.35% | 2.14% | 2.63% | 3.27% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.34 | 0.31 | 0.15 | 0.30 | 0.56 |
| Diluted EPS (Rs.) | 0.34 | 0.31 | 0.15 | 0.30 | 0.56 |
| Cash EPS (Rs.) | 0.34 | 0.25 | 0.06 | 0.29 | 0.56 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 18.28 | 15.54 | 13.48 | 8.68 | 8.38 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 18.28 | 15.54 | 13.48 | 8.68 | 8.38 |
| Revenue From Operations / Share (Rs.) | 3.65 | 2.88 | 6.01 | 10.91 | 13.36 |
| PBDIT / Share (Rs.) | 0.44 | 0.33 | 0.15 | 0.42 | 0.76 |
| PBIT / Share (Rs.) | 0.44 | 0.33 | 0.15 | 0.42 | 0.76 |
| PBT / Share (Rs.) | 0.44 | 0.33 | 0.14 | 0.40 | 0.75 |
| Net Profit / Share (Rs.) | 0.34 | 0.24 | 0.05 | 0.29 | 0.56 |
| PBDIT Margin (%) | 12.24 | 11.78 | 2.62 | 3.85 | 5.74 |
| PBIT Margin (%) | 12.11 | 11.54 | 2.49 | 3.85 | 5.74 |
| PBT Margin (%) | 12.07 | 11.48 | 2.48 | 3.74 | 5.65 |
| Net Profit Margin (%) | 9.34 | 8.57 | 0.99 | 2.71 | 4.19 |
| Return on Networth / Equity (%) | 1.86 | 1.59 | 0.44 | 3.41 | 6.67 |
| Return on Capital Employeed (%) | 2.41 | 2.14 | 1.11 | 4.83 | 9.16 |
| Return On Assets (%) | 1.85 | 1.50 | 0.40 | 1.57 | 5.13 |
| Asset Turnover Ratio (%) | 0.26 | 0.21 | 0.77 | 0.73 | 1.31 |
| Current Ratio (X) | 106.66 | 12.68 | 9.46 | 1.82 | 4.12 |
| Quick Ratio (X) | 106.38 | 12.29 | 9.31 | 1.44 | 4.12 |
| Interest Coverage Ratio (X) | 375.85 | 186.88 | 169.54 | 35.00 | 64.00 |
| Interest Coverage Ratio (Post Tax) (X) | 287.60 | 137.00 | 65.14 | 25.67 | 47.67 |
| Enterprise Value (Cr.) | 87.10 | 50.86 | 13.59 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 14.19 | 18.87 | 3.36 | 0.00 | 0.00 |
| EV / EBITDA (X) | 115.87 | 160.10 | 127.69 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 14.25 | 18.96 | 3.42 | 0.00 | 0.00 |
| Price / BV (X) | 2.84 | 3.52 | 1.52 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 14.26 | 18.96 | 3.42 | 0.00 | 0.00 |
| EarningsYield | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
After reviewing the key financial ratios for Achyut Healthcare Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 0.34. This value is below the healthy minimum of 5. It has increased from 0.31 (Mar 23) to 0.34, marking an increase of 0.03.
- For Diluted EPS (Rs.), as of Mar 24, the value is 0.34. This value is below the healthy minimum of 5. It has increased from 0.31 (Mar 23) to 0.34, marking an increase of 0.03.
- For Cash EPS (Rs.), as of Mar 24, the value is 0.34. This value is below the healthy minimum of 3. It has increased from 0.25 (Mar 23) to 0.34, marking an increase of 0.09.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 18.28. It has increased from 15.54 (Mar 23) to 18.28, marking an increase of 2.74.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 18.28. It has increased from 15.54 (Mar 23) to 18.28, marking an increase of 2.74.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 3.65. It has increased from 2.88 (Mar 23) to 3.65, marking an increase of 0.77.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 0.44. This value is below the healthy minimum of 2. It has increased from 0.33 (Mar 23) to 0.44, marking an increase of 0.11.
- For PBIT / Share (Rs.), as of Mar 24, the value is 0.44. This value is within the healthy range. It has increased from 0.33 (Mar 23) to 0.44, marking an increase of 0.11.
- For PBT / Share (Rs.), as of Mar 24, the value is 0.44. This value is within the healthy range. It has increased from 0.33 (Mar 23) to 0.44, marking an increase of 0.11.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 0.34. This value is below the healthy minimum of 2. It has increased from 0.24 (Mar 23) to 0.34, marking an increase of 0.10.
- For PBDIT Margin (%), as of Mar 24, the value is 12.24. This value is within the healthy range. It has increased from 11.78 (Mar 23) to 12.24, marking an increase of 0.46.
- For PBIT Margin (%), as of Mar 24, the value is 12.11. This value is within the healthy range. It has increased from 11.54 (Mar 23) to 12.11, marking an increase of 0.57.
- For PBT Margin (%), as of Mar 24, the value is 12.07. This value is within the healthy range. It has increased from 11.48 (Mar 23) to 12.07, marking an increase of 0.59.
- For Net Profit Margin (%), as of Mar 24, the value is 9.34. This value is within the healthy range. It has increased from 8.57 (Mar 23) to 9.34, marking an increase of 0.77.
- For Return on Networth / Equity (%), as of Mar 24, the value is 1.86. This value is below the healthy minimum of 15. It has increased from 1.59 (Mar 23) to 1.86, marking an increase of 0.27.
- For Return on Capital Employeed (%), as of Mar 24, the value is 2.41. This value is below the healthy minimum of 10. It has increased from 2.14 (Mar 23) to 2.41, marking an increase of 0.27.
- For Return On Assets (%), as of Mar 24, the value is 1.85. This value is below the healthy minimum of 5. It has increased from 1.50 (Mar 23) to 1.85, marking an increase of 0.35.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.26. It has increased from 0.21 (Mar 23) to 0.26, marking an increase of 0.05.
- For Current Ratio (X), as of Mar 24, the value is 106.66. This value exceeds the healthy maximum of 3. It has increased from 12.68 (Mar 23) to 106.66, marking an increase of 93.98.
- For Quick Ratio (X), as of Mar 24, the value is 106.38. This value exceeds the healthy maximum of 2. It has increased from 12.29 (Mar 23) to 106.38, marking an increase of 94.09.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 375.85. This value is within the healthy range. It has increased from 186.88 (Mar 23) to 375.85, marking an increase of 188.97.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 287.60. This value is within the healthy range. It has increased from 137.00 (Mar 23) to 287.60, marking an increase of 150.60.
- For Enterprise Value (Cr.), as of Mar 24, the value is 87.10. It has increased from 50.86 (Mar 23) to 87.10, marking an increase of 36.24.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 14.19. This value exceeds the healthy maximum of 3. It has decreased from 18.87 (Mar 23) to 14.19, marking a decrease of 4.68.
- For EV / EBITDA (X), as of Mar 24, the value is 115.87. This value exceeds the healthy maximum of 15. It has decreased from 160.10 (Mar 23) to 115.87, marking a decrease of 44.23.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 14.25. This value exceeds the healthy maximum of 3. It has decreased from 18.96 (Mar 23) to 14.25, marking a decrease of 4.71.
- For Price / BV (X), as of Mar 24, the value is 2.84. This value is within the healthy range. It has decreased from 3.52 (Mar 23) to 2.84, marking a decrease of 0.68.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 14.26. This value exceeds the healthy maximum of 3. It has decreased from 18.96 (Mar 23) to 14.26, marking a decrease of 4.70.
- For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 23) to 0.01, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Achyut Healthcare Ltd:
- Net Profit Margin: 9.34%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 2.41% (Industry Average ROCE: 16.56%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.86% (Industry Average ROE: 14.72%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 287.6
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 106.38
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 143 (Industry average Stock P/E: 74.01)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 9.34%
About the Company - Qualitative Analysis
Achyut Healthcare Ltd. is a Public Limited Listed company incorporated on 11/01/1996 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L67120GJ1996PLC028600 and registration number is 028600. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 6.14 Cr. and Equity Capital is Rs. 16.83 Cr. for the Year ended 31/03/2024.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Pharmaceuticals | 610, Colonade, B/H Iscon Temple, Opposite Iscon, BRTS Bus Stand, Ahmedabad Gujarat 380058 | mahendrazenith@hotmail.com http://www.achyuthealthcare.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mahendra Chatrabhuj Raycha | Chairman & Non-Exe.Director |
| Mr. Jigen Jagdishbhai Modi | Managing Director |
| Ms. Amisha Jigen Modi | Executive Director |
| Mr. Akshit Mahendra Raycha | Non Executive Director |
| Mr. Rutvik Sanjaykumar Thakkar | Independent Director |
| Mrs. Sonu Lalitkumar Jain | Independent Director |
FAQ
What is the intrinsic value of Achyut Healthcare Ltd?
Achyut Healthcare Ltd's intrinsic value (as of 01 June 2025) is ₹2.75 — 17.42% lower the current market price of 3.33, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 78.4 Cr. market cap, FY2025-2026 high/low of ₹6.25/2.82, reserves of 14.28 Cr, and liabilities of 31.93 Cr.
What is the Market Cap of Achyut Healthcare Ltd?
The Market Cap of Achyut Healthcare Ltd is 78.4 Cr..
What is the current Stock Price of Achyut Healthcare Ltd as on 01 June 2025?
The current stock price of Achyut Healthcare Ltd as on 01 June 2025 is 3.33.
What is the High / Low of Achyut Healthcare Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Achyut Healthcare Ltd stocks is ₹6.25/2.82.
What is the Stock P/E of Achyut Healthcare Ltd?
The Stock P/E of Achyut Healthcare Ltd is 143.
What is the Book Value of Achyut Healthcare Ltd?
The Book Value of Achyut Healthcare Ltd is 1.33.
What is the Dividend Yield of Achyut Healthcare Ltd?
The Dividend Yield of Achyut Healthcare Ltd is 0.00 %.
What is the ROCE of Achyut Healthcare Ltd?
The ROCE of Achyut Healthcare Ltd is 2.26 %.
What is the ROE of Achyut Healthcare Ltd?
The ROE of Achyut Healthcare Ltd is 1.77 %.
What is the Face Value of Achyut Healthcare Ltd?
The Face Value of Achyut Healthcare Ltd is 1.00.